CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

DSGNDesign Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $12.57 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$786.65M
RECENT INSIDER TRADES
  • 2025-08-14 · William Arsani (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders144
Shares held47,463,799
Value$642.59M
Percent of shares outstanding75.84%
As of quarter end2026-06-30
RECENT NEWS
  • Design Therapeutics: 'Hold' DT-216P2 Registrational FA Plans Q4 2026 And 12-Week Results Q1 2027
  • Design Therapeutics a new overweight at Wells Fargo on Friedreich ataxia program
  • Broad Lantern Media Expands Local SEO and Web Design Services to Include Home Service Businesses Throughout the Poconos
  • Best Software for Vinyl Cutting Design (2026): CorelDRAW Recognized for Production-Ready Vector Design by Software Experts
  • Five Reputable Decorative Wall Panel Manufacturers in China 2026: Advancing Interior Design Solutions
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Design Therapeutics, Inc. (DSGN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit